Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Champions Oncolog (CSBR)

Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,854
  • Shares Outstanding, K 13,594
  • Annual Sales, $ 53,870 K
  • Annual Income, $ -5,340 K
  • 60-Month Beta 0.39
  • Price/Sales 1.27
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CSBR with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -43.61%)
  • Historical Volatility 41.36%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 307.73% on 12/21/23
  • IV Low 0.00% on 04/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 6.47
  • Today's Open Interest 657
  • Open Int (30-Day) 440

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +525,889.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.76 +6.19%
on 04/08/24
5.50 -8.00%
on 03/21/24
-0.04 (-0.78%)
since 03/19/24
3-Month
4.76 +6.19%
on 04/08/24
6.80 -25.59%
on 01/22/24
-1.61 (-24.13%)
since 01/19/24
52-Week
4.17 +21.34%
on 05/12/23
7.32 -30.87%
on 07/17/23
-0.20 (-3.80%)
since 04/19/23

Most Recent Stories

More News
Champions Oncology, Inc. (CSBR) Reports Q3 Loss, Tops Revenue Estimates

Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200% and 2.26%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?...

CSBR : 5.06 (-0.10%)
GANX : 3.18 (+0.95%)
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 9.52% and 4.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AMRX : 5.42 (+1.12%)
CSBR : 5.06 (-0.10%)
ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates

ImmunoGen (IMGN) delivered earnings and revenue surprises of 20.69% and 132.98%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IMGN : 31.23 (unch)
CSBR : 5.06 (-0.10%)
Implied Volatility Surging for Champions Oncology (CSBR) Stock Options

Investors need to pay close attention to Champions Oncology (CSBR) stock based on the movements in the options market lately.

CSBR : 5.06 (-0.10%)
Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Lags Revenue Estimates

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 7.30% and 9.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

ENTA : 13.32 (+0.68%)
CSBR : 5.06 (-0.10%)
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of -30% and 24.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MDWD : 15.77 (-7.18%)
CSBR : 5.06 (-0.10%)
Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Lags Revenue Estimates

Infinity (INFI) delivered earnings and revenue surprises of -140% and 91.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

INFI : 0.0080 (-50.00%)
CSBR : 5.06 (-0.10%)
Champions Oncology, Inc. (CSBR) Reports Q1 Loss, Tops Revenue Estimates

Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -300% and 2.27%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?

CSBR : 5.06 (-0.10%)
ISR : 0.3840 (+0.03%)
Champions Oncology Reports Quarterly Revenue of $12.9 Million

Record Annual Revenue of $49.1 Million

CSBR : 5.06 (-0.10%)
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022

HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic...

CSBR : 5.06 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the...

See More

Key Turning Points

3rd Resistance Point 5.12
2nd Resistance Point 5.11
1st Resistance Point 5.09
Last Price 5.06
1st Support Level 5.05
2nd Support Level 5.04
3rd Support Level 5.02

See More

52-Week High 7.32
Fibonacci 61.8% 6.12
Fibonacci 50% 5.74
Fibonacci 38.2% 5.37
Last Price 5.06
52-Week Low 4.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar